|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.00 USD | -0.78% |
|
-2.83% | +1.02% |
| 08:55am | Enlivex Therapeutics to Delist From Tel Aviv Stock Exchange | MT |
| 01-22 | Nasdaq CEO Adena Friedman on AI Transformation, Reforms | MT |
| Capitalization | 56.4B 47.97B 44.46B 41.55B 77.46B 5,182B 82.1B 508B 202B 2,447B 211B 207B 8,900B | P/E ratio 2025 * |
34.4x | P/E ratio 2026 * | 31.1x |
|---|---|---|---|---|---|
| Enterprise value | 65.95B 56.09B 51.99B 48.58B 90.57B 6,059B 96B 594B 236B 2,861B 247B 242B 10,407B | EV / Sales 2025 * |
12.6x | EV / Sales 2026 * | 11.1x |
| Free-Float |
76.01% | Yield 2025 * |
1.06% | Yield 2026 * | 1.19% |
Last Transcript: Nasdaq, Inc.
| 1 day | -0.77% | ||
| 1 week | -2.83% | ||
| Current month | +1.02% | ||
| 1 month | +0.11% | ||
| 3 months | +10.47% | ||
| 6 months | +11.15% | ||
| Current year | +1.02% |
| 1 week | 97.13 |  | 100.2 |
| 1 month | 95.8 | | 101.78 |
| Current year | 95.8 | | 101.78 |
| 1 year | 64.84 | | 101.78 |
| 3 years | 46.88 | | 101.78 |
| 5 years | 44.74 | | 101.78 |
| 10 years | 18.75 | | 101.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adena Friedman
CEO | Chief Executive Officer | 56 | 2016-12-31 |
P. Griggs
PSD | President | 55 | 2023-04-17 |
Sarah Youngwood
DFI | Director of Finance/CFO | - | 2023-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Mike Splinter
CHM | Chairman | 74 | 2017-05-09 |
Essa Al-Mulla
BRD | Director/Board Member | 67 | 2008-02-29 |
Charlene Begley
BRD | Director/Board Member | 59 | 2014-05-06 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | -2.83% | +21.09% | +57.45% | 56.4B | |
| -0.67% | -0.43% | +9.87% | +59.42% | 99.41B | |
| -1.03% | -3.78% | +44.22% | +14.55% | 69.12B | |
| +0.50% | -4.53% | -26.44% | +19.65% | 59.71B | |
| -0.28% | +1.09% | -9.11% | +31.69% | 46.08B | |
| +0.77% | +3.28% | +52.08% | +24.43% | 15.14B | |
| +1.27% | -0.85% | +45.88% | +90.23% | 14.45B | |
| -0.25% | -0.41% | +9.48% | +62.21% | 14.28B | |
| -1.28% | -1.61% | +10.25% | +86.21% | 10.37B | |
| -0.62% | -2.36% | +12.42% | +180.60% | 8.5B | |
| Average | -0.25% | -0.94% | +16.97% | +62.64% | 39.35B | |
| Weighted average by Cap. | -0.43% | -1.07% | +12.78% | +45.18% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.23B 4.44B 4.12B 3.85B 7.18B 480B 7.61B 47.09B 18.69B 227B 19.6B 19.2B 825B | 5.67B 4.83B 4.47B 4.18B 7.79B 521B 8.26B 51.13B 20.3B 246B 21.28B 20.84B 895B |
| Net income | 1.65B 1.41B 1.3B 1.22B 2.27B 152B 2.41B 14.9B 5.92B 71.76B 6.2B 6.08B 261B | 1.8B 1.53B 1.42B 1.32B 2.47B 165B 2.61B 16.18B 6.42B 77.9B 6.73B 6.6B 283B |
| Net Debt | 9.55B 8.12B 7.53B 7.03B 13.11B 877B 13.9B 86.02B 34.15B 414B 35.8B 35.07B 1,507B | 6.64B 5.65B 5.24B 4.89B 9.12B 610B 9.67B 59.86B 23.77B 288B 24.91B 24.4B 1,048B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-23 | 98.07 $ | -0.72% | 1,212,669 |
| 26-01-22 | 98.78 $ | 0.00% | 3,361,967 |
| 26-01-21 | 98.78 $ | +1.41% | 3,189,815 |
| 26-01-20 | 97.41 $ | -3.54% | 3,209,023 |
| 26-01-16 | 100.98 $ | +0.65% | 3,768,181 |
Delayed Quote Nasdaq, January 23, 2026 at 02:57 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NDAQ Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition